心力衰竭中低氯血症的预后及探索性神经激素相关因素:多中心队列研究
这项多中心前瞻性队列研究纳入3941例因急性或恶化性心衰出院且检测血清氯的患者,按出院氯水平分为低氯、正常氯和高氯血症。多变量调整后,低氯血症与全因死亡、心血管死亡、心衰再住院及复合终点独立相关,竞争风险分析显示超额死亡风险主要为心血管性。在499例预设亚组中,循环UCN2与血清氯呈适度负相关。
要点
- 低氯血症与心衰患者2年全因死亡、心血管死亡、心衰再住院及复合终点独立相关。
- 同时纳入氯和钠的模型中,氯仍与全因死亡独立相关,而钠不然。
- 探索性分析提示循环UCN2与血清氯水平存在适度负相关,需机制研究验证。
核心结论
- 低氯血症可识别心血管风险显著增加的心衰患者,且独立于已建立的预后标志物。
- 探索性分析提示循环UCN2与氯稳态可能存在关联,值得机制研究。
研究设计与样本
- 多中心前瞻性队列研究,纳入3941例因急性或恶化性心衰出院且具备血清氯检测的患者。
- 按出院氯水平分为低氯血症、正常氯血症和高氯血症,评估2年结局。
- 采用多变量Cox比例风险模型和竞争风险模型分析氯状态与结局的关联。
- 在预设的499例患者亚组中探索性分析循环UCN2浓度。
主要发现
- 多变量调整后,低氯血症与全因死亡独立相关(调整HR 2.09;95%CI 1.64-2.67;p<0.001)。
- 低氯血症与心血管死亡独立相关(调整HR 2.29;95%CI 1.64-3.20;p<0.001)。
- 低氯血症与心衰再住院独立相关(调整HR 1.30;95%CI 1.02-1.67;p=0.04)。
- 低氯血症与复合终点独立相关(调整HR 1.46;95%CI 1.20-1.78;p<0.001)。
- 竞争风险分析显示低氯血症相关超额死亡风险主要为心血管性;同时纳入氯和钠的模型中,氯仍与全因死亡独立相关而钠不然。
临床怎么用
- 心衰患者出院时检测血清氯有助于识别心血管风险显著增加的高危人群。
- 评估心衰预后时,氯的预后信息独立于钠,不应仅关注血钠。
局限性
- UCN2分析为探索性,样本仅499例,关联强度有限。
- 低氯血症与不良结局的关联为观察性,不能推断因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypochloraemia has emerged as a prognostic marker in heart failure, although the mechanisms underlying chloride dysregulation remain incompletely understood. We evaluated the prognostic significance of serum chloride levels and explored clinical and biochemical correlates of hypochloraemia including circulating urocortin 2 (UCN2). METHODS: This multicentre prospective cohort study included 3941 patients discharged after hospitalisation for acute or worsening heart failure with available serum chloride measurements. Patients were categorised according to discharge chloride levels as hypochloraemia, normochloraemia or hyperchloraemia. Associations between chloride status and 2-year outcomes were assessed using multivariable Cox proportional hazards and competing risk models. Exploratory analyses of circulating UCN2 concentrations were performed in a predefined subset of 499 patients. RESULTS: Hypochloraemia was independently associated with adverse outcomes after multivariable adjustment, including all-cause mortality (adjusted HR, 2.09; 95% CI 1.64 to 2.67; p<0.001), cardiovascular mortality (adjusted HR, 2.29; 95% CI 1.64 to 3.20; p<0.001), heart failure rehospitalisation (adjusted HR, 1.30; 95% CI 1.02 to 1.67; p=0.04) and the composite outcome (adjusted HR, 1.46; 95% CI 1.20 to 1.78; p<0.001). Competing risk analyses demonstrated that the excess mortality risk associated with hypochloraemia was predominantly cardiovascular. In models including both serum chloride and sodium, chloride remained independently associated with all-cause mortality whereas sodium did not. In exploratory analyses, circulating UCN2 concentrations showed a modest inverse association with serum chloride levels after adjustment for sodium, renal function, nutritional status and clinical severity (B=-0.37; 95% CI -0.72 to -0.02; p=0.04). CONCLUSIONS: Hypochloraemia identified patients with heart failure at substantially increased cardiovascular risk independent of established prognostic markers. Exploratory analyses suggested a potential association between circulating UCN2 and chloride homeostasis that warrants mechanistic investigation.
引用
- Inukai, Takefuji, Kazama, et al. Prognostic and exploratory neurohormonal correlates of hypochloraemia in heart failure: a multicentre cohort study. Heart. 2026. PMID: 42638074. doi:10.1136/heartjnl-2026-328053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。